首页> 外文OA文献 >Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
【2h】

Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.

机译:使用Pvcs和Pvmsp1的间日疟原虫的实用PCR基因分型方案。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Plasmodium vivax is the second most prevalent malaria parasite affecting more than 75 million people each year, mostly in South America and Asia. In addition to major morbidity this parasite is associated with relapses and a reduction in birthweight. The emergence and spread of drug resistance in Plasmodium falciparum is a major factor in the resurgence of this parasite. P. vivax resistance to drugs has more recently emerged and monitoring the situation would be helped, as for P. falciparum, by molecular methods that can be used to characterize parasites in field studies and drug efficacy trials. METHODS: Practical PCR genotyping protocols based on polymorphic loci present in two P. vivax genetic markers, Pvcs and Pvmsp1, were developed. The methodology was evaluated using 100 P. vivax isolates collected in Thailand. RESULTS AND DISCUSSION: Analysis revealed that P. vivax populations in Thailand are highly diverse genetically, with mixed genotype infections found in 26 % of the samples (average multiplicity of infection = 1.29). A large number of distinguishable alleles were found for the two markers, 23 for Pvcs and 36 for Pvmsp1. These were generally randomly distributed amongst the isolates. A total of 68 distinct genotypes could be enumerated in the 74 isolates with a multiplicity of infection of 1. CONCLUSION: These results indicate that the genotyping protocols presented can be useful in the assessment of in vivo drug efficacy clinical trials conducted in endemic areas and for epidemiological studies of P. vivax infections.
机译:背景:间日疟原虫是第二大最普遍的疟原虫,每年感染超过7500万人,主要在南美和亚洲。除了主要的发病率外,这种寄生虫还与复发和出生体重减轻有关。恶性疟原虫中耐药性的出现和扩散是该寄生虫复活的主要因素。间日疟原虫对药物的抗药性近来已经出现,对于恶性疟原虫,通过分子方法可用于现场研究和药物功效试验来表征寄生虫,从而有助于监测情况。方法:开发了基于两个间日疟原虫遗传标记Pvcs和Pvmsp1中存在的多态性基因座的实用PCR基因分型方案。使用在泰国收集的100个间日疟原虫分离株对方法进行了评估。结果与讨论:分析显示泰国的间日疟原虫种群在遗传上高度多样化,在26%的样本中发现混合基因型感染(平均感染倍数= 1.29)。对于这两个标记,发现了大量可区分的等位基因,其中Pvcs为23个,Pvmsp1为36个。这些通常随机地分布在分离物中。在74株感染率为1的分离株中,总共可以列举68种不同的基因型。结论:这些结果表明,提出的基因分型方案可用于评估在流行地区进行的体内药物疗效临床试验,并用于间日疟原虫感染的流行病学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号